Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel
About this episode
This week, IBD Chief Content Officer Chris Gessel joined the podcast to discuss "vertical violations," which can be used to spot prolonged sell-offs. We also look at three stocks that are bucking the downtrend: Repligen, Anaplan and Insulet. Plus, Randy Watts of William O'Neil + Co. returns for a sponsored interview with Doug Peebles, Chief Investment Officer of Fixed Income at AllianceBernstein, about fixed income strategies. For the video version, show notes and charts, go to investors.com/podcast.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Investing With IBD publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Investing With IBD
Is A Market Pivot Ahead? Key Moves For A September Shift
Investing With IBD
Monster Moves, Long-Term Trends And Wisdom For Your Portfolio
Investing With IBD
Measure It And Protect It. Indicators You Can Use To Defend Your Portfolio.
Investing With IBD
How To Use This Key Indicator As A Measure Of Stability
Investing With IBD